Medical AI Platform OpenEvidence Secures $200M in Latest Funding Round Valued at $6 Billion
The medical AI sector continues to attract significant investment as OpenEvidence reportedly secures $200 million in new funding. The platform, which doctors compare to a medical version of ChatGPT, has seen rapid adoption since its 2022 launch according to industry reports.
Medical AI Platform Achieves Major Funding Milestone
OpenEvidence, an artificial intelligence platform that healthcare professionals have described as a specialized ChatGPT for medical applications, has reportedly secured $200 million in new funding at a $6 billion valuation, according to The New York Times. This substantial investment comes just three months after the company raised $210 million at a $3.5 billion valuation, indicating continued strong investor confidence in specialized AI applications for specific industries.